PACIRA BIOSCIENCES, INC. Proceeds from Long-Term Debt Issued
PACIRA BIOSCIENCES, INC. (PCRX) reported Proceeds from Long-Term Debt Issued of -$4.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2017-03-01
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for the quarter ending 2012-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for the quarter ending 2012-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for fiscal 2016 was -$4.00K.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for fiscal 2015 was -$1.47M.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for fiscal 2014 was $0.00.
- PACIRA BIOSCIENCES, INC. proceeds from issuance of long-term debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$4.00K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | -$1.47M 10-K · filed 2017-03-01 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 | ||
| 2013-09-30 | $0.00 10-Q · filed 2013-10-31 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $27.50M 10-K · filed 2015-02-24 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $27.50M 10-Q · filed 2013-10-31 | ||
| 2012-06-30 | $27.50M 10-Q · filed 2013-08-06 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |